XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY Share-Based Compensation (Notes)
3 Months Ended
Mar. 31, 2018
STOCKHOLDERS' EQUITY
STOCKHOLDERS’ EQUITY

Stock-Based Compensation

Information with respect to option shares granted under all of our stock incentive plans for the three months ended March 31, 2018 was as follows:
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Options outstanding at January 1, 2018
2,290,017


2,290,017

$9.65
 
 
Granted



$—
 
 
Exercised



$—
 
 
Forfeited or canceled
(28,490
)

(28,490
)
$21.55
 
 
Options outstanding at March 31, 2018
2,261,527


2,261,527

$9.50
1.18
$—
Options vested at March 31, 2018 or expected to vest
 
 
2,261,527

$9.50
1.08
$—
Options exercisable at March 31, 2018
 
 
2,261,527

$9.50
1.18
$—


Information with respect to our non-vested restricted stock units for the three months ended March 31, 2018 was as follows:
 
Non-Vested Restricted Stock Units
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Grant-Date
Fair Value
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Non-vested at January 1, 2018
1,809,138

1,254,110

3,063,248

$5.10
 
 
Granted
803,159

732,884

1,536,043

$4.55
 
 
Vested
(222,232
)

(222,232
)
$5.62
 
 
Forfeited
(448,001
)
(757,247
)
(1,205,248
)
$5.33
 
 
Non-vested at March 31, 2018
1,942,064

1,229,747

3,171,811

$4.71
1.26
$14,368
Expected to vest
 
 
2,674,948

$4.88
1.26
$12,118


Stock-based compensation was included in the following captions in our condensed consolidated statements of operations for the three months ended March 31, 2018 and 2017 (in thousands):
 
Three Months Ended March 31,
 
2018

2017
Cost of products revenues
$
19

 
$
15

Cost of services revenues
34

 
49

Research and development expenses
152

 
88

Marketing and selling expenses
360

 
356

General and administrative expenses
138

 
903

 
$
703

 
$
1,411